Whole genome sequencing at Genomics England – Dr. Joanne Mason

January 11, 2017

Dr. Joanne Mason describes the 100,000 genomes project at Genomics England. The project aims to create a new genomic medicine service and enable medical research by combining genomic sequence data with medical records on a national scale. Dr. Mason presents the challenges they faced in getting started and their progress to-date (as of May 2016 when this presentation was filmed at Illumina’s Genomics in Oncology Summit.)

Speaker: Joanne Mason, PhD Director of Sequencing & Sample Acquisition, Genomics England

Learn more about Genomics in Oncology, visit our website here.

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.

Subscribe to the Illumina video channel 

View customer spotlight videos 

View Illumina webinars 

View Illumina product videos 

View Illumina support videos 

Share this article on